Goserelin Acetate

้†‹้…ธๆˆˆ่ˆ็‘žๆž—

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameGoserelin Acetate
Drug Alias NameGoserelinum้†‹้…ธๆ€ง็‘žๆž—Goserelinaๆˆˆ่ˆ็‘žๆž—้†‹้…ธ็›Goserelin acetate implant (AstraZeneca) +[12]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone receptor agonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsMetastatic breast cancerRadiation InjuriesMetrorrhagia +[9]ย 
Global Approved IndicationsEndometriosisProstatic NeoplasmsBreast Neoplasms
Approved Indications in ChinaEndometriosisProstatic NeoplasmsBreast Neoplasms
Original Approved Country/TerritoryUnited States
Original Approved Date1989/12/29
Country/TerritoryCzechiaCanadaUnited States +[17]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active IndicationsMetastatic breast cancerRadiation InjuriesMetrorrhagia +[8]ย 
Inactive IndicationsNeoplasms

Other Information

ATC CodeL02AE03